For patients using currently available injectable GLP-1 medications , common errors include injecting into the same site repeatedly, failing to allow refrigerated medication to reach room temperature before injection, not rotating injection sites properly, and incorrect pen device technique
Typically, youll need a BMI of 40 or greater, or a BMI of 35 or greater with a serious obesity-related health condition like type 2 diabetes, severe sleep apnea, or hypertension
Given the potential for GLP-1 RA to affect heart rates [30], a meta-analysis of 43 RCTs using GLP-1 RAs showed no increased risk of AF with GLP-1 RAs [39]
Albiglutide use in patients with HFrEF and diabetes was well tolerated, with subjects mainly reporting gastrointestinal events
The door is open for science-enabled nutrition companies to step in and prove they can deliver real effects without crossing legal lines